Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Liver function and drug processing: a closer look at bulevirtide

NCT ID NCT05765344

First seen Jan 04, 2026 · Last updated May 24, 2026 · Updated 26 times

Summary

This study looked at how the drug bulevirtide (BLV) enters and leaves the bloodstream in people with normal and reduced liver function. Researchers measured drug levels and bile acids, and checked safety after multiple doses. The goal was to understand how liver impairment affects the drug, not to treat a disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Clinical Pharmacology of Miami, LLC

    Miami, Florida, 33014, United States

  • Orange County Research Center

    Lake Forest, California, 92630, United States

  • Orlando Clinical Research Center

    Orlando, Florida, 32809, United States

  • Pinnacle Clinical Research LLC

    San Antonio, Texas, 78229, United States

  • Texas Liver Institute

    San Antonio, Texas, 78215, United States

  • University of Miami

    Miami, Florida, 33136, United States

Conditions

Explore the condition pages connected to this study.